3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Advanced Solid Tumor
1
Interventions
pembrolizumab
26
Cisplatin
15
Pemetrexed
14
Paclitaxel
14
Carboplatin
14
Nivolumab
10
Cyclophosphamide
10
Docetaxel
8
atezolizumab
7
Injections
7
Melphalan
6
tislelizumab
5
olaparib
5
Gemcitabine
5
Filgrastim
5
durvalumab
4
aldesleukin
4
Leucovorin
4
Irinotecan
4
Granulocyte Colony-Stimulating Factor
4
Etoposide
4
Bevacizumab
4
tocilizumab
3
spartalizumab
3
liposomal doxorubicin
3
ixabepilone
3
fludarabine
3
epacadostat
3
defactinib
3
adavosertib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Appointments and Schedules
×
Other solid neoplasm
×
Clear all
NCT06560632
2026-01-16
POLAR
Repare Therapeutics
Phase 1
Terminated
26 enrolled
14 charts